{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T20:53:18Z","timestamp":1787345598590,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:00:00Z","timestamp":1541203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["NSERC-DG-2018-23"],"award-info":[{"award-number":["NSERC-DG-2018-23"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00726-018-2673-9","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T03:38:06Z","timestamp":1541216286000},"page":"383-393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria"],"prefix":"10.1007","volume":"51","author":[{"given":"Ronald","family":"Domalaon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Brizuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Eisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Findlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Zhanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-5519","authenticated-orcid":false,"given":"Frank","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,3]]},"reference":[{"key":"2673_CR1","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00726-014-1778-z","volume":"46","author":"M Ahn","year":"2014","unstructured":"Ahn M, Jacob B, Gunasekaran P et al (2014) Poly-lysine peptidomimetics having potent antimicrobial activity without hemolytic activity. Amino Acids 46:2259\u20132269. \n                    https:\/\/doi.org\/10.1007\/s00726-014-1778-z","journal-title":"Amino Acids"},{"key":"2673_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22122173","author":"MA Dawgul","year":"2017","unstructured":"Dawgul MA, Greber KE, Bartoszewska S et al (2017) In vitro evaluation of cytotoxicity and permeation study on lysine- and arginine-based lipopeptides with proven antimicrobial activity. Molecules. \n                    https:\/\/doi.org\/10.3390\/molecules22122173","journal-title":"Molecules"},{"key":"2673_CR3","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1007\/s00726-014-1806-z","volume":"46","author":"R Domalaon","year":"2014","unstructured":"Domalaon R, Yang X, O\u2019Neil J et al (2014) Structure-activity relationships in ultrashort cationic lipopeptides: the effects of amino acid ring constraint on antibacterial activity. Amino Acids 46:2517\u20132530. \n                    https:\/\/doi.org\/10.1007\/s00726-014-1806-z","journal-title":"Amino Acids"},{"key":"2673_CR4","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2174\/1568026615666150915112459","volume":"16","author":"R Domalaon","year":"2016","unstructured":"Domalaon R, Zhanel GG, Schweizer F (2016) Short antimicrobial peptides and peptide scaffolds as promising antibacterial agents. Curr Top Med Chem 16:1217\u20131230. \n                    https:\/\/doi.org\/10.2174\/1568026615666150915112459","journal-title":"Curr Top Med Chem"},{"key":"2673_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2018.07.018","author":"R Domalaon","year":"2018","unstructured":"Domalaon R, Berry L, Tays Q et al (2018a) Development of dilipid polymyxins: investigation on the effect of hydrophobicity through its fatty acyl component. Bioorg Chem. \n                    https:\/\/doi.org\/10.1016\/j.bioorg.2018.07.018","journal-title":"Bioorg Chem"},{"key":"2673_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00077-17","author":"R Domalaon","year":"2018","unstructured":"Domalaon R, Idowu T, Zhanel GG, Schweizer F (2018b) Antibiotic hybrids: the next generation of agents and adjuvants against Gram-negative pathogens? Clin Microbiol Rev. \n                    https:\/\/doi.org\/10.1128\/cmr.00077-17","journal-title":"Clin Microbiol Rev"},{"key":"2673_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02374-17","author":"R Domalaon","year":"2018","unstructured":"Domalaon R, Sanchak Y, Koskei LC et al (2018c) Short proline-rich lipopeptide potentiates minocycline and rifampin against multidrug- and extensively drug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. \n                    https:\/\/doi.org\/10.1128\/aac.02374-17","journal-title":"Antimicrob Agents Chemother"},{"key":"2673_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10096-014-2219-3","volume":"34","author":"Q Feng","year":"2015","unstructured":"Feng Q, Huang Y, Chen M et al (2015) Functional synergy of alpha-helical antimicrobial peptides and traditional antibiotics against Gram-negative and Gram-positive bacteria in vitro and in vivo. Eur J Clin Microbiol Infect Dis 34:197\u2013204. \n                    https:\/\/doi.org\/10.1007\/s10096-014-2219-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2673_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijantimicag.2012.03.013","volume":"40","author":"B Findlay","year":"2012","unstructured":"Findlay B, Zhanel GG, Schweizer F (2012) Investigating the antimicrobial peptide \u201cwindow of activity\u201d using cationic lipopeptides with hydrocarbon and fluorinated tails. Int J Antimicrob Agents 40:36\u201342. \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.03.013","journal-title":"Int J Antimicrob Agents"},{"key":"2673_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd3591","volume":"11","author":"CD Fjell","year":"2011","unstructured":"Fjell CD, Hiss JA, Hancock REW, Schneider G (2011) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11:37\u201351. \n                    https:\/\/doi.org\/10.1038\/nrd3591","journal-title":"Nat Rev Drug Discov"},{"key":"2673_CR11","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s00726-014-1744-9","volume":"46","author":"KE Greber","year":"2014","unstructured":"Greber KE, Dawgul M, Kamysz W et al (2014) Biological and surface-active properties of double-chain cationic amino acid-based surfactants. Amino Acids 46:1893\u20131898. \n                    https:\/\/doi.org\/10.1007\/s00726-014-1744-9","journal-title":"Amino Acids"},{"key":"2673_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fmicb.2017.00123","volume":"8","author":"KE Greber","year":"2017","unstructured":"Greber KE, Dawgul M, Kamysz W, Sawicki W (2017) Cationic net charge and counter ion type as antimicrobial activity determinant factors of short lipopeptides. Front Microbiol 8:123. \n                    https:\/\/doi.org\/10.3389\/fmicb.2017.00123","journal-title":"Front Microbiol"},{"issue":"Suppl 1","key":"2673_CR13","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/jac\/dkt021","volume":"68","author":"DJ Hoban","year":"2013","unstructured":"Hoban DJ, Zhanel GG (2013) Introduction to the CANWARD study (2007-11). J Antimicrob Chemother 68(Suppl 1):i3\u2013i5","journal-title":"J Antimicrob Chemother"},{"key":"2673_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ijantimicag.2017.02.012","volume":"49","author":"P Jorge","year":"2017","unstructured":"Jorge P, Perez-Perez M, Perez Rodriguez G et al (2017) A network perspective on antimicrobial peptide combination therapies: the potential of colistin, polymyxin B and nisin. Int J Antimicrob Agents 49:668\u2013676. \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.02.012","journal-title":"Int J Antimicrob Agents"},{"key":"2673_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jelechem.2017.12.065","volume":"812","author":"J Juhaniewicz-D\u0119bi\u0144ska","year":"2018","unstructured":"Juhaniewicz-D\u0119bi\u0144ska J, Tymecka D, S\u0119k S (2018) Lipopeptide-induced changes in permeability of solid supported bilayers composed of bacterial membrane lipids. J Electroanal Chem 812:227\u2013234. \n                    https:\/\/doi.org\/10.1016\/j.jelechem.2017.12.065","journal-title":"J Electroanal Chem"},{"key":"2673_CR16","doi-asserted-by":"publisher","first-page":"15997","DOI":"10.1073\/pnas.0606129103","volume":"103","author":"A Makovitzki","year":"2006","unstructured":"Makovitzki A, Avrahami D, Shai Y (2006) Ultrashort antibacterial and antifungal lipopeptides. Proc Natl Acad Sci USA 103:15997\u201316002. \n                    https:\/\/doi.org\/10.1073\/pnas.0606129103","journal-title":"Proc Natl Acad Sci USA"},{"key":"2673_CR17","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","volume":"44","author":"N Masuda","year":"2000","unstructured":"Masuda N, Sakagawa E, Ohya S et al (2000) Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44:3322\u20133327","journal-title":"Antimicrob Agents Chemother"},{"key":"2673_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/AAC.00999-09","volume":"54","author":"J Meletiadis","year":"2010","unstructured":"Meletiadis J, Pournaras S, Roilides E, Walsh TJ (2010) Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumi. Antimicrob Agents Chemother 54:602\u2013609. \n                    https:\/\/doi.org\/10.1128\/AAC.00999-09","journal-title":"Antimicrob Agents Chemother"},{"key":"2673_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.resmic.2011.11.002","volume":"163","author":"K Naghmouchi","year":"2012","unstructured":"Naghmouchi K, Le Lay C, Baah J, Drider D (2012) Antibiotic and antimicrobial peptide combinations: synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants. Res Microbiol 163:101\u2013108. \n                    https:\/\/doi.org\/10.1016\/j.resmic.2011.11.002","journal-title":"Res Microbiol"},{"key":"2673_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbapap.2005.10.019","volume":"1764","author":"Y Park","year":"2006","unstructured":"Park Y, Park SN, Park S-C et al (2006) Synergism of Leu-Lys rich antimicrobial peptides and chloramphenicol against bacterial cells. Biochim Biophys Acta 1764:24\u201332. \n                    https:\/\/doi.org\/10.1016\/j.bbapap.2005.10.019","journal-title":"Biochim Biophys Acta"},{"key":"2673_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.femsre.2004.04.001","volume":"28","author":"S Schwarz","year":"2004","unstructured":"Schwarz S, Kehrenberg C, Doublet B, Cloeckaert A (2004) Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol Rev 28:519\u2013542. \n                    https:\/\/doi.org\/10.1016\/j.femsre.2004.04.001","journal-title":"FEMS Microbiol Rev"},{"key":"2673_CR22","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1128\/AAC.01245-15","volume":"59","author":"O Soren","year":"2015","unstructured":"Soren O, Brinch KS, Patel D et al (2015) Antimicrobial peptide novicidin synergizes with rifampin, ceftriaxone, and ceftazidime against antibiotic-resistant Enterobacteriaceae in vitro. Antimicrob Agents Chemother 59:6233\u20136240. \n                    https:\/\/doi.org\/10.1128\/AAC.01245-15","journal-title":"Antimicrob Agents Chemother"},{"key":"2673_CR23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/jac\/dkp346","volume":"64","author":"JN Steenbergen","year":"2009","unstructured":"Steenbergen JN, Mohr JF, Thorne GM (2009) Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies. J Antimicrob Chemother 64:1130\u20131138. \n                    https:\/\/doi.org\/10.1093\/jac\/dkp346","journal-title":"J Antimicrob Chemother"},{"key":"2673_CR24","volume-title":"Performance standards for antimicrobial susceptibility testing CLSI supplement M100S","author":"The Clinical and Laboratory Standards Institute","year":"2016","unstructured":"The Clinical and Laboratory Standards Institute (2016) Performance standards for antimicrobial susceptibility testing CLSI supplement M100S, 26th edn. Clin. Lab. Stand Institute, Wayne, PA","edition":"26"},{"key":"2673_CR25","unstructured":"World Health Organization (2015) The selection and use of essential medicines. Report of the WHO Expert Committee, 2015 (including the 19th WHO Model List of Essential Medicines and the 5th WHO Model List of Essential Medicines for Children)"},{"key":"2673_CR26","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1128\/AAC.01538-07","volume":"52","author":"GG Zhanel","year":"2008","unstructured":"Zhanel GG, DeCorby M, Laing N et al (2008) Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother 52:1430\u20131437. \n                    https:\/\/doi.org\/10.1128\/AAC.01538-07","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-018-2673-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-018-2673-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-018-2673-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T20:15:49Z","timestamp":1572725749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-018-2673-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2673"],"URL":"https:\/\/doi.org\/10.1007\/s00726-018-2673-9","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,3]]},"assertion":[{"value":"14 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the University of Manitoba which the studies were conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all the individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}